Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
John J. NicolsPresident & CEO770,0741.95%2014-06-13
Dr. Patrick Y. Yang, PhDN/A229,5150.58%2014-11-18
Mr. Douglas T. SheehySVP, General Counsel & Sec.209,1450.53%2014-08-10
Bernard KelleyDirector160,9490.41%2014-06-11
James LalondeSVP, R&D150,2420.38%2014-08-10
Thomas R. BaruchDirector138,4510.35%2014-06-11
Mr. Byron L. DorganN/A135,9510.34%2014-06-11
Mr. Dennis P. WolfN/A135,9510.34%2014-06-11
Mr. David D. O'TooleSVP & CFO110,6870.28%2013-09-04
Dr. David L. AntonSVP, BioIndustrials93,7770.24%2013-02-10

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Yang Patrick YDirector2014-11-18Buy20,000229,515$2.354762.55Link
Yang Patrick YDirector2014-11-17Buy20,000209,515$2.3446.863.25Link
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner2014-11-10Sell2,921,2250$2.376923.361.18Link
Yang Patrick YDirector2014-08-12Buy60,000189,515$2.22133.272.07Link
NICOLS JOHN JPresident & CEO
(Click for the stocks that their CEOs have bought)
2013-03-08Buy27,000911,000$2.4265.357.85Link
NICOLS JOHN JPresident & CEO2013-03-07Buy54,000884,000$2.22119.972.07Link
O'Toole David DSVP & CFO2013-03-04Buy10,000115,384$2.0220.289.11Link
O'Toole David DSVP & CFO2012-11-12Buy5,00060,000$2.21173.64Link
O'Toole David DSVP & CFO2012-09-14Buy5,00055,000$2.7813.937.41Link
Sheehy Douglas T.SVP, General Counsel & Sec.2012-09-14Sell3,80069,200$2.7610.538.41Link
Anton David L.SVP, BioIndustrials2012-09-14Sell3,80070,200$2.7610.538.41Link
SHAW ALANPresident and CEO2011-12-16Sell53,846277,000$5.28284.3-27.65Link
SHAW ALANPresident and CEO2011-12-14Sell37,820330,846$5.27199.3-27.51Link
SHAW ALANPresident and CEO2011-07-07Sell15,000368,666$10.13152-62.29Link
SHAW ALANPresident and CEO2011-06-02Sell15,000368,666$10.39155.9-63.23Link
Lawson Robert JSVP and CFO2011-05-11Buy2,00044,000$9.519-59.79Link
SHAW ALANPresident and CEO2011-05-02Sell15,000268,666$10.44156.6-63.41Link
SHAW ALANPresident and CEO2011-04-01Sell15,000268,666$12.07181.1-68.35Link
SHAW ALANPresident and CEO2011-03-01Sell15,000218,666$10.65159.8-64.13Link
SHAW ALANPresident and CEO2011-02-11Sell15,000218,666$10.46156.9-63.48Link
BARUCH THOMAS RDirector2010-08-27Buy2,5002,742,658$7.5518.9-49.4Link
Pasternack Bruce ADirector2010-08-24Buy10,00010,000$7.7877.8-50.9Link
SHAW ALANPresident and CEO2010-08-10Buy2,00096,132$816-52.25Link
Sheehy Douglas T.SVP, Gen Counsel and Sec.2010-08-10Buy1,0001,000$7.998-52.19Link
Sarret Joseph J.CBO, President Pharmaceuticals2010-08-10Buy2,00015,333$7.9916-52.19Link
Lawson Robert JSVP and CFO2010-08-10Buy2,0002,000$816-52.25Link
Anton David L.SVP, Research and Development2010-08-10Buy2,0002,000$7.9916-52.19Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK